CYP2C9*2 is associated with indomethacin treatment failure for patent ductus arteriosus
{{output}}
Aims: To identify clinical andgenetic factors associated with indomethacin treatment failure in preterm neonates with patent ductus arteriosus (PDA). Patients & Methods: This is a multicenter cohort study of 144 preterm infants (22-32 weeks gestational age) at... ...